Cargando…

Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment

OBJECTIVE: To determine the preferred regimen for women with adenomyosis undergoing in vitro fertilization (IVF), we compared the IVF outcomes of fresh embryo transfer (ET) cycles with or without gonadotropin-releasing hormone (GnRH) agonist pretreatment and of frozen-thawed embryo transfer (FET) cy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Chan Woo, Choi, Min Hye, Yang, Kwang Moon, Song, In Ok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Reproductive Medicine 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039310/ https://www.ncbi.nlm.nih.gov/pubmed/27689040 http://dx.doi.org/10.5653/cerm.2016.43.3.169

Ejemplares similares

Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis
por: Li, Muzi, et al.
Publicado: (2021)

Pregnancy outcomes in women with adenomyosis, undergoing artificial endometrial preparation with and without gonadotropin-releasing hormone agonist pretreatment in frozen embryo transfer cycles: An RCT
por: Eslami Moayed, Marzieh, et al.
Publicado: (2023)

Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer
por: Wang, Yu, et al.
Publicado: (2023)

Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes
por: Qi, Qianrong, et al.
Publicado: (2020)

Endometrial Preparation for Women Undergoing Embryo Transfer Frozen-Thawed Embryo Transfer With and Without Pretreatment With Gonadotropin Releasing Hormone Agonists
por: Movahedi, Shohreh, et al.
Publicado: (2018)

Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: A randomized, multi-center study
por: Aflatoonian, Abbas, et al.
Publicado: (2018)

Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist
por: Ji, Hui, et al.
Publicado: (2022)

Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer
por: Ding, Xiaoyan, et al.
Publicado: (2021)

Comparison of the clinical outcome of frozen-thawed embryo transfer with and without pretreatment with a gonadotropin-releasing hormone agonist
por: Kang, Jieun, et al.
Publicado: (2018)

Comparison of letrozole with gonadotropin-releasing hormone agonist in frozen embryo transfer after recurrent implantation failure: An RCT
por: Khadem Ghaebi, Nayere, et al.
Publicado: (2020)

Single-dose administration of a short-acting gonadotropin-releasing hormone agonist does not affect cycle outcome in frozen–thawed embryo transfer cycles
por: Wang, Hanbi, et al.
Publicado: (2021)

Association Between Fresh Embryo Transfers and Frozen–Thawed Embryo Transfers Regarding Live Birth Rates Among Women Undergoing Long Gonadotropin-Releasing Hormone Antagonist Protocols
por: Fan, Li, et al.
Publicado: (2022)

Single Dose Gonadotropin-Releasing Hormone Agonist Luteal Support in Fresh Embryo Transfer: Variation in Timing, Type, and Dosage
por: Abu, Muhammad Azrai, et al.
Publicado: (2022)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
por: Carosso, Andrea Roberto, et al.
Publicado: (2021)

Gonadotropin-releasing hormone agonist combined with hormone replacement therapy does not improve the reproductive outcomes of frozen-thawed embryo transfer cycle in elderly patients: a retrospective study
por: Dong, Mei, et al.
Publicado: (2020)

Gonadotropin-releasing hormone agonist for ovulation trigger – OHSS prevention and use of modified luteal phase support for fresh embryo transfer
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

Artificial Endometrial Preparation for Frozen-Thawed Embryo Transfer with or without Pretreatment with Depot Gonadotropin Releasing Hormone Agonist in Women with Regular Menses
por: Azimi Nekoo, Elham, et al.
Publicado: (2015)

Endometrial preparation using gonadotropin-releasing hormone agonist prior to frozen-thawed embryo transfer in women with repeated implantation failure: An RCT
por: Davar, Robab, et al.
Publicado: (2020)

Dual Trigger with Gonadotropin Releasing Hormone Agonist and Human Chorionic Gonadotropin of Fresh Autologous Cycles in High Responders: A Systematic Review
por: Vyrides, Andreas A, et al.
Publicado: (2022)

Gonadotropin-releasing hormone agonist downregulation combined with hormone replacement therapy improves the reproductive outcome in frozen–thawed embryo transfer cycles for patients of advanced reproductive age with idiopathic recurrent implantation failure
por: Pan, Dan, et al.
Publicado: (2022)

Perinatal outcome in fresh versus frozen embryo transfer in ART cycles
por: Aflatoonian, Ali, et al.
Publicado: (2016)

Efficacy of Combined Levonorgestrel-Releasing Intrauterine System with Gonadotropin-Releasing Hormone Analog for the Treatment of Adenomyosis
por: Zhang, Peihai, et al.
Publicado: (2013)

Intramuscular injection of human chorionic gonadotropin prior to secretory transformation in patients undergoing frozen-thawed embryo transfer cycles
por: Deng, Ling, et al.
Publicado: (2020)

Human chorionic gonadotropin-administered natural cycle versus spontaneous ovulatory cycle in patients undergoing two pronuclear zygote frozen-thawed embryo transfer
por: Lee, You-Jung, et al.
Publicado: (2018)

Is Human Chorionic Gonadotropin Trigger Beneficial for Natural Cycle Frozen-Thawed Embryo Transfer?
por: Gao, Dan-Dan, et al.
Publicado: (2021)

Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011)

The effect of fresh IVF cycle characteristics on frozen embryo transfer (FET) outcomes
por: Bushaqer, Nayla J., et al.
Publicado: (2020)

Live births from in vitro fertilization-embryo transfer following the administration of gonadotropin-releasing hormone agonist without gonadotropins: Two case reports
por: Li, Mai, et al.
Publicado: (2023)

A Validated Model for Individualized Prediction of Live Birth in Patients With Adenomyosis Undergoing Frozen–Thawed Embryo Transfer
por: Wu, Yaoqiu, et al.
Publicado: (2022)

Presence of Adenomyosis Impairs Clinical Outcomes in Women Undergoing Frozen Embryo Transfer: A Retrospective Cohort Study
por: Sachs-Guedj, Noémie, et al.
Publicado: (2023)

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
por: Tehraninejad, Ensieh Sh., et al.
Publicado: (2010)

Effects of localisation of uterine adenomyosis on outcome of in vitro fertilisation/intracytoplasmic sperm injection fresh and frozen-thawed embryo transfer cycles: a multicentre retrospective cohort study
por: Iwasawa, Takuya, et al.
Publicado: (2021)

Effect of Adding Human Chorionic Gonadotropin to The Endometrial Preparation Protocol in Frozen Embryo Transfer Cycles
por: Eftekhar, Maryam, et al.
Publicado: (2012)

Effect of Adding Human Chorionic Gonadotropin to The Endometrial Preparation Protocol in Frozen Embryo Transfer Cycles
por: Eftekhar, Maryam, et al.
Publicado: (2021)

Gonadotropin-Releasing Hormone agonist (GnRH-a) Pretreatment before Hormone Replacement Therapy Does Not Improve Reproductive Outcomes of Frozen–Thawed Embryo Transfer Cycle in Older Patients with Intrauterine Fibroid: A Retrospective Cohort Study
por: Sun, Ping, et al.
Publicado: (2023)

Gonadotropin-releasing hormone agonist triggering of oocyte maturation in assisted reproductive technology cycles
por: Türkgeldi, Engin, et al.
Publicado: (2015)

Gonadotropin-releasing hormone agonist-induced pituitary apoplexy
por: Keane, Fergus, et al.
Publicado: (2016)

Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls
por: Shiasi Arani, Kobra, et al.
Publicado: (2015)

Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy
por: Yu, Xiaoling, et al.
Publicado: (2021)

Effect of adding human chorionic gonadotropin to frozen thawed embryo transfer cycles with history of thin endometrium
por: Davar, Robab, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n7fdh9g4fpgrm4scj5dff3o0ds